DEXCOM INC (DXCM)
US2521311074 - Common Stock
1 Reason to Sell DexCom Stock, and 1 Reason to Buy
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday.
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Friday.
Nasdaq 100 Movers: ODFL, DXCM
What's going on in today's session: S&P500 movers
Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Friday as we examine the latest happenings in today's session.
Dexcom Launches the First Generative AI Platform in Glucose Biosensing
3 Reasons to Buy DexCom Stock Like There's No Tomorrow
Exploring the Growth Potential of NASDAQ:DXCM as It Nears a Breakout.
Exploring the Growth Potential of DEXCOM INC (NASDAQ:DXCM) as It Nears a Breakout.
2 Excellent Healthcare Stocks to Hold Through the Next Decade
These Are the 5 Worst-Performing Stocks in the Nasdaq-100 With 2024 Almost Over
Noteworthy Monday Option Activity: DXCM, RKLB, FL
2 Superior Growth Stocks to Buy Right Now If You have $1,000 to Invest
Friday Sector Laggards: Utilities, Healthcare
Dexcom and ŌURA Announce Strategic Partnership
Nasdaq 100 Movers: AMAT, DXCM
S&P 500 Movers: AMAT, PLTR
Notable Tuesday Option Activity: CRWD, HON, DXCM
Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues
Shares soared out of a buy zone after beating third-quarter forecasts and raising its outlook for 2024.
1 Stock to Buy Near Its 52-Week Low and Hold for 10 Years
This medical device company is down but not out.
Why DexCom Stock Flopped on Friday
Investors likely felt that with a compelling new product on the market, the company should have posted more meaningful growth.
Stock Market Mixed But Nasdaq Hits Record High As Tesla Leads Earnings Winners: Weekly Review
The major indexes were mixed for the week.
Nasdaq 100 Movers: DXCM, GFS
DexCom (DXCM) Q3 2024 Earnings Call Transcript
DXCM earnings call for the period ending September 30, 2024.
Noteworthy Thursday Option Activity: DXCM, KKR, KNX
Dexcom Tops Quarterly Expectations And Keeps Its Guidance. But Shares Crash.
The company continues to expect 11% to 13% organic sales growth this year.
